Suppr超能文献

等待治疗的影响:社交焦虑障碍随机对照试验中等待名单对照组的荟萃分析

The Effects of Waiting for Treatment: A Meta-Analysis of Waitlist Control Groups in Randomized Controlled Trials for Social Anxiety Disorder.

作者信息

Steinert Christiane, Stadter Katja, Stark Rudolf, Leichsenring Falk

机构信息

Clinic of Psychosomatic Medicine and Psychotherapy, University of Giessen, Giessen, Germany.

Department of Psychotherapy and Systems Neuroscience, University of Giessen, Giessen, Germany.

出版信息

Clin Psychol Psychother. 2017 May;24(3):649-660. doi: 10.1002/cpp.2032. Epub 2016 Jul 22.

Abstract

UNLABELLED

Social anxiety disorder (SAD) is a highly prevalent mental disorder. However, little is known about how SAD changes in subjects who do not receive treatment. Waitlist control groups (WLCGs) are frequently included in randomized controlled trials (RCTs) on the treatment of mental disorders. Data from WLCGs are of value as they provide information on the untreated short-term course of a disorder and may serve as disorder-specific norms of change (benchmarks) against which treatment outcomes of SAD can be compared. Thus, we performed a meta-analysis focusing on the effects occurring in WLCGs of RCTs for SAD. Our study was conducted along the PRISMA guidelines. Thirty RCTs (total n = 2460) comprising 30 WLCGs and 47 treatment groups were included. Mean waiting time was 10.6 weeks. The pooled effect of waiting on SAD measures was g = 0.128 (95% CI: 0.057-0.199). Effects regarding other forms of anxiety, depression and functioning were of similarly small size. In contrast, change in the treatment groups was large, both within (g = 0.887) and between groups (g = 0.860). Our results show that for SAD, changes occurring in WLCGs of RCTs are small. The findings may serve as benchmarks in pilot studies of a new treatment or as an additional comparison in studies comparing two active treatments. For psychotherapy research in general, the small effect sizes found in WLCGs confirm that testing a treatment against a waiting list is not a very strict test. Further research on WLCGs in specific mental disorders is required, for example examining the expectancies of patients randomized to waiting. Copyright © 2016 John Wiley & Sons, Ltd.

KEY PRACTITIONER MESSAGE

In clinical practice, patients suffering from a mental disorder often have to wait for treatment. By analyzing data from waitlist control groups we can gain estimates of symptom change that occur during waiting. It could be seen that waiting for treatment only results in a negligible effect. Thus, in the short-term (i.e., 10.6 weeks) time is no healer in social anxiety disorder. Our results are similar to previous meta-analyses on the effects of waiting in other disorders, e.g., depression and posttraumatic stress disorder.

摘要

未标注

社交焦虑障碍(SAD)是一种高度流行的精神障碍。然而,对于未接受治疗的患者中社交焦虑障碍如何变化,我们知之甚少。等待名单对照组(WLCGs)经常被纳入精神障碍治疗的随机对照试验(RCTs)中。来自等待名单对照组的数据很有价值,因为它们提供了关于一种疾病未经治疗的短期病程的信息,并且可以作为特定疾病变化的标准(基准),据此可比较社交焦虑障碍的治疗效果。因此,我们进行了一项荟萃分析,重点关注社交焦虑障碍随机对照试验中等待名单对照组所出现的效应。我们的研究是按照PRISMA指南进行的。纳入了30项随机对照试验(共n = 2460),包括30个等待名单对照组和47个治疗组。平均等待时间为10.6周。等待对社交焦虑障碍测量指标的合并效应为g = 0.128(95%置信区间:0.057 - 0.199)。关于其他形式焦虑、抑郁和功能的效应同样较小。相比之下,治疗组内(g = 0.887)和组间(g = 0.860)的变化很大。我们的结果表明,对于社交焦虑障碍,随机对照试验中等待名单对照组出现的变化很小。这些发现可作为新治疗方法初步研究的基准,或作为比较两种有效治疗方法的研究中的额外对照。总体而言,对于心理治疗研究,在等待名单对照组中发现的小效应量证实了与等待名单对照来测试一种治疗方法并不是一个非常严格的检验。需要对特定精神障碍中的等待名单对照组进行进一步研究,例如考察被随机分配到等待组的患者的期望。版权所有© 2016约翰威立父子有限公司。

关键从业者信息

在临床实践中,患有精神障碍的患者常常不得不等待治疗。通过分析等待名单对照组的数据,我们可以获得等待期间症状变化的估计值。可以看出,等待治疗只会产生微不足道的效果。因此,在短期内(即10.6周),时间并不能治愈社交焦虑障碍。我们的结果与之前关于等待在其他障碍(如抑郁症和创伤后应激障碍)中影响的荟萃分析相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验